Form 4: Caris Life Sciences Director Receives Stock Grant
Insider Transaction (Form 4)
Jeff L Vacirca, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.
Summary
- Grant/award: acquired 13,192 Common Stock on August 14, 2026; holds 62,863 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jeff L Vacirca — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Grant/award | Common Stock | 13,192 | — | — | 62,863 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Grant/award (13,192 shares) |
Keywords
insider transaction, Form 4, CAI, Caris Life Sciences, Inc., neutral, Jeff L Vacirca
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.